RECRUITING

Increasing PrEP With Trans Women in the Deep South

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this to address barriers and facilitators to PrEP uptake, and encourage adherence among trans women via a single arm stepped wedge clinical trial. The main question is to compare PrEP uptake and adherence outcomes among trans women in the T'Cher intervention to the delayed study arm.

Official Title

T'Cher, Take Charge: Increasing PrEP Awareness, Uptake and Adherence Through Health Care Empowerment and Addressing Social Determinants of Health Among Racially Diverse Trans Women in the Deep South

Quick Facts

Study Start:2023-01-31

Study Completion:2026-07-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT05689281

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:FEMALE

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Provision of signed and dated informed consent form * Declaration of willingness to comply with all study procedures and availability during the study * Age 18 years old or older * Male sex designated at birth * Identify as trans woman, woman or another gender identity not associated with being a man * Desire to use or re-start PrEP * HIV uninfected * Speaks English or Spanish * Live in the New Orleans metropolitan statistical area (which includes 8 parishes)	* Confirmed HIV infection by rapid algorithm testing and/or laboratory testing (described above) * Prior or current participation in the active arm of an HIV vaccine trial with evidence of vaccine-induced seropositivity * Concurrent or planned enrollment in a research study that provides PrEP * Unwilling to attend quarterly follow-up visits, which will include survey participation * Has any other condition which, based on the opinion of the investigator, would preclude provision of informed consent; make participation in the project unsafe; complicate interpretation of outcome data; or otherwise interfere with achieving the project objectives

Inclusion Criteria

Exclusion Criteria

* Provision of signed and dated informed consent form
* Declaration of willingness to comply with all study procedures and availability during the study
* Age 18 years old or older
* Male sex designated at birth
* Identify as trans woman, woman or another gender identity not associated with being a man
* Desire to use or re-start PrEP
* HIV uninfected
* Speaks English or Spanish
* Live in the New Orleans metropolitan statistical area (which includes 8 parishes)

* Confirmed HIV infection by rapid algorithm testing and/or laboratory testing (described above)
* Prior or current participation in the active arm of an HIV vaccine trial with evidence of vaccine-induced seropositivity
* Concurrent or planned enrollment in a research study that provides PrEP
* Unwilling to attend quarterly follow-up visits, which will include survey participation
* Has any other condition which, based on the opinion of the investigator, would preclude provision of informed consent; make participation in the project unsafe; complicate interpretation of outcome data; or otherwise interfere with achieving the project objectives

Contacts and Locations

Study Contact

Narquis Barak, MS

CONTACT

504.821.2601

narquis.barak@crescentcare.org

Erin Meek, DrPH

CONTACT

628-217-6113

erin.wilson@sfdph.org

Study Locations (Sites)

NO/AIDS Task Force d.b.a. CrescentCare

New Orleans, Louisiana, 70117

United States

Collaborators and Investigators

Sponsor: CrescentCare

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-01-31

Study Completion Date2026-07-31

Study Record Updates